Pakistan and Russia recently engaged in discussions regarding potential collaborations in the pharmaceutical industry aimed at establishing joint ventures. The meeting, led by Haroon Akhtar Khan, Special Assistant to the Prime Minister on Industries and Production, delved into bilateral relations and cooperation on initiatives like joint ventures in the pharmaceutical sector. Key attendees included Denis Nazarov from the Russian government, along with officials from Pakistan’s Ministry of Industries and Production, Ministry of National Health Services, and the Drug Regulatory Authority of Pakistan (DRAP).
One of the primary focal points of the meeting was evaluating the prospects of importing insulin from Russia and advancing pharmaceutical joint ventures between the two nations. The DRAP had previously granted registration to Genetics Pharmaceuticals in Lahore for importing insulin from the Russian company Zavod Medsintez. Discussions also touched on matters related to applications for adjustments in maximum retail prices, notably addressing the potential cost implications of such changes compared to existing insulin options in the market.
SAPM Haroon Akhtar Khan underscored the strategic significance of fostering pharmaceutical joint ventures between Pakistan and Russia, emphasizing the benefits such collaborations could bring to diabetic patients in Pakistan, a significant consumer of insulin. He highlighted ongoing efforts aligned with the government’s vision to kickstart local insulin manufacturing within Pakistan. Plans are in motion to finalize a joint protocol between local manufacturers and Russian entities, with a comprehensive proposal expected to be presented before the federal cabinet following further development.
The establishment of pharmaceutical joint ventures between Pakistan and Russia not only signifies a crucial step towards strengthening bilateral relations but also holds the potential to bolster the local healthcare ecosystem and ensure a stable supply of vital medications like insulin. As the two countries navigate the intricacies of these collaborations, the focus remains on promoting self-sufficiency in pharmaceutical manufacturing and enhancing healthcare access for the populace. The groundwork laid in these discussions sets the stage for future advancements in the pharmaceutical landscape, promising a mutually beneficial partnership in the realm of healthcare innovation.
Key Takeaways:
– Collaboration discussions between Pakistan and Russia in the pharmaceutical sector aim to establish joint ventures for local manufacturing.
– Initiatives like importing insulin from Russia and advancing pharmaceutical joint ventures hold promise for enhancing healthcare access.
– Efforts are underway to finalize protocols for policy board implementation and present a comprehensive proposal to the federal cabinet.
– Establishing joint ventures in pharma not only strengthens bilateral relations but also paves the way for self-sufficiency in drug manufacturing and improved healthcare services.
Read more on brecorder.com